Table 2 Recurring patients
Patient No. | Initial stage | EBV DNA at diagnosis (copies/ml) | EBV DNA at the end of treatment (copies/ml) | EBV DNA at recurrence (copies/ml) | Time to recurrence (months) |
|---|---|---|---|---|---|
1 | T2N3 | 290,000 | < 350 | 2,135 | 14 |
2 | T4N2 | 9,600 | < 350 | 900 | 25 |
3 | T3N2 | 12,745 | < 350 | < 350 | 18 |
4 | T2N1 | 3,300 | < 350 | < 350 | 26 |
5 | T2N3 | 87,425 | 7,820 | 4,398,000 | 11 |
6 | T3N2 | 1,240 | < 350 | 9,185 | 12 |
7 | T2N2 | 7,290 | 1,560 | 15,290 | 12 |